The honest version goes like this. If you’re carrying extra fat and sleeping badly, ipamorelin paired with real training and nutrition might help your testosterone read better over months. If your testosterone is low for a medical reason, ipamorelin is the wrong tool, and a clinician should look at proper testosterone therapy instead. The same rule applies to picking the most effective form of BPC-157. The compound supports the work. It doesn’t replace it.
References:
Andersen, N. B., Malmlöf, K., Johansen, P. B., Andreassen, T. T., Ørtoft, G., & Oxlund, H. (2001). The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats. Growth Hormone & IGF Research, 11(5), 266–272. https://pubmed.ncbi.nlm.nih.gov/11735244/
Beck, D. E., Sweeney, W. B., & McCarter, M. D. (2014). Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Diseases of the Colon & Rectum, 57(12), 1401–1408. https://pubmed.ncbi.nlm.nih.gov/25331030/
Gobburu, J. V., Agersø, H., Jusko, W. J., & Ynddal, L. (1999). Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical Research, 16(9), 1412–1416. https://pubmed.ncbi.nlm.nih.gov/10496658/
Johansen, P. B., Nowak, J., Skjaerbaek, C., Flyvbjerg, A., Andreassen, T. T., Wilken, M., & Orskov, H. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone & IGF Research, 9(2), 106–113. https://pubmed.ncbi.nlm.nih.gov/10373343/
Raun, K., Hansen, B. S., Johansen, N. L., Thøgersen, H., Madsen, K., Ankersen, M., & Andersen, P. H. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552–561. https://pubmed.ncbi.nlm.nih.gov/9849822/